Leiden University Medical Centre
Luís Almeida is a Portuguese biochemist. He did his bachelor’s in Biochemistry at the University of Lisbon. After graduating, he was accepted into a binational master’s degree in Infection Biology, between the Catholic University of Córdoba, in Argentina, where he studied for one year, and the Hannover Medical School, in Germany, where he studied for another year. It was also in Germany where he did his master’s thesis, at the TWINCORE Centre for Experimental and Clinical Infection Research, on the topic of “The immunomodulatory properties of Mycobacterium tuberculosis secretory proteins”, under the supervision of Prof. Dr. med. Tim Sparwasser, and Prof. Dr. Hugo Luján.
After completing his M. Sc. in Infection Biology, he was accepted as a Marie-Curie PhD student, at the Leiden University Medical Centre, in the Netherlands, as part of the ArthritisHeal consortium, where he is currently studying the effects of pro-resolving lipids on immunometabolism and immune polarization of myeloid cells in the context of rheumatic diseases, under the supervision of Prof. Dr. Maria Yazdanbakhsh, and Dr. Bart Everts.
University of Glasgow
Patrícia is originally from Slovakia and graduated with a bachelor’s degree in Medicinal Chemistry from Slovak University of Technology where she focused on nanomaterials and their effect on human health and the environment. Her master’s degree in Medical Biotechnology was undertaken at Aalborg University in Denmark, where she worked in a field of cancer research and immunology. The main research areas included bioinformatics, molecular biology, protein chemistry (antibodies) and histology, which involved a collaboration with a hospital in Denmark.
Currently, Patrícia is conducting PhD research under a supervision of Prof. Carl Goodyear in rheumatoid arthritis at the University of Glasgow at the institute of infection, immunity and inflammation (https://www.gla.ac.uk/researchinstitutes/iii/). The group she is a part of is focused on understanding of immunopathogenesis of various diseases, mostly arthritis, and finding viable treatment with a combination of clinical and laboratory research.
Patrícia’s PhD project aims to test different specialised pro-resolving mediators (SPMs) on osteoclasts differentiated from pre-cursors in both inflammatory and homeostatic conditions. The project also aims to identify receptors present on osteoclasts, their association with pro-resolving lipids and related signalling pathways. This will provide an in-depth understanding of the role of SPMs in normal skeletal health and osteolytic disease, which could lead to ways of therapeutically resolving inflammation-driven bone disease.